A Systematic Review of Cancer of Unknown Primary in the Head and Neck Region

References

• ChernockRD, LewisJS. Approach to metastatic carcinoma of unknown primary in the head and neck: squamous cell carcinoma and beyond. Head Neck Pathol. 2015;9(1):6–15. doi:10.1007/s12105-015-0616-225804376
   PubMedGoogle Scholar
• DorobiszK, Wlodarska-PolinskaI, Pazdro-ZastawnyK, et al. The impact of the patient’s condition, diagnostic procedures and treatment on the survival of carcinoma of unknown primary site patients. Cancer Manag Res. 2019;11:6603–6614. Published 2019 Jul 16. doi:10.2147/CMAR.S20434631406475
   PubMed Web of Science ®Google Scholar
• LosaF, IglesiasL, PanéM, et al. 2018 consensus statement by the Spanish society of pathology and the Spanish society of medical oncology on the diagnosis and treatment of cancer of unknown primary. Clin Transl Oncol. 2018;20(11):1361–1372. doi:10.1007/s12094-018-1899-z29808414
   PubMed Web of Science ®Google Scholar
• StellaGM, SenettaR, CassentiA, RoncoM, CassoniP. Cancers of unknown primary origin: current perspectives and future therapeutic strategies. J Transl Med. 2012;10(1):12. Published 2012 Jan 24. doi:10.1186/1479-5876-10-1222272606
   PubMed Web of Science ®Google Scholar
• KamalM, MohamedASR, FullerCD, et al. Patterns of failure after intensity modulated radiation therapy in head and neck squamous cell carcinoma of unknown primary: implication of elective nodal and mucosal dose coverage. Adv Radiat Oncol. 2020;5(5):929–935. Published 2020 May 15. doi:10.1016/j.adro.2020.04.02533083655
   PubMedGoogle Scholar
• Müller von der GrünJ, TahtaliA, GhanaatiS, RödelC, BalermpasP. Diagnostic and treatment modalities for patients with cervical lymph node metastases of unknown primary site - current status and challenges. Radiat Oncol. 2017;12(1):82. Published 2017 May 10. doi:10.1186/s13014-017-0817-928486947
   PubMed Web of Science ®Google Scholar
• López-LázaroM. The migration ability of stem cells can explain the existence of cancer of unknown primary site. Rethinking metastasis. Oncoscience. 2015;2(5):467–475. Published 2015 May 1. doi:10.18632/oncoscience.15926097879
   PubMedGoogle Scholar
• RassyE, AssiT, PavlidisN. Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?Br J Cancer. 2020;122:1124–1132. doi:10.1038/s41416-019-0723-z32042068
   PubMed Web of Science ®Google Scholar
• RashidA, HessKR, LenziR, et al. Overexpression and prevalence of molecular markers in patients with cancer of unknown primary (CUP). Proc Am Soc Clin Oncol. 2005;24:9683. n.d.Return to ref 57 in article. doi:10.1200/jco.2005.23.16_suppl.9683
   Google Scholar
• van de WouwAJ, JansenRLH, GriffioenAW, HillenHFP. Clinical and immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT. Anticancer Res. 2004;24:297–301.15015611
   PubMed Web of Science ®Google Scholar
• KaravasilisV, Malamou-MitsiV, BriasoulisE, et al. Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer. 2005;5(1):25. doi:10.1186/1471-2407-5-2515743540
   PubMed Web of Science ®Google Scholar
• KaravasilisV, Malamou-MitsiV, BriasoulisE, et al. Matrix metalloproteinases in carcinoma of unknown primary. Cancer. 2005;104(10):2282–2287. doi:10.1002/cncr.2145416220559
   PubMed Web of Science ®Google Scholar
• GatalicaZ, XiuJ, SwensenJ, VranicS. Comprehensive analysis of cancers of unknown primary for the biomarkers of response to immune checkpoint blockade therapy. Eur J Cancer. 2018;94:179–186. Return to ref 56 in article. doi:10.1016/j.ejca.2018.02.02129571084
   PubMed Web of Science ®Google Scholar
• PentheroudakisG, PetrakisD, GoussiaA, et al. 1450 POSTER immunohistochemical profiling of signalling pathways in Cancer of Unknown Primary (CUP). Eur J Cancer. 2011;47:S184. doi:10.1016/S0959-8049(11)70943-1
   Web of Science ®Google Scholar
• HedleyDW, LearyJA, KirstenF. Metastatic adenocarcinoma of unknown primary site: abnormalities of cellular DNA content and survival. Eur J Cancer Clin Oncol. 1985;21:185–189. doi:10.1016/0277-5379(85)90171-33987755
   PubMedGoogle Scholar
• NatoliC, RamazzottiV, NappiO, et al. Unknown primary tumors. Biochim Biophys Acta. 2011;1816(1):13–24.21371531
   PubMed Web of Science ®Google Scholar
• PantouD, TsarouhaH, PapadopoulouA, et al. Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management. Neoplasia. 2003;5:23–31. doi:10.1016/S1476-5586(03)80014-312659667
   PubMed Web of Science ®Google Scholar
• WangY, HeSS, BaoY, et al. Cervical lymph node carcinoma metastasis from unknown primary site: a retrospective analysis of 154 patients. Cancer Med. 2018;7(5):1852–1859. doi:10.1002/cam4.145829608251
   PubMed Web of Science ®Google Scholar
• JonesW, AllardiceG, ScottI, OienK, BrewsterD, MorrisonSD. Cancers of unknown primary diagnosed during hospitalization: a population-based study. BMC Cancer. 2017;17:85. doi:10.1186/s12885-017-3083-128143449
   PubMed Web of Science ®Google Scholar
• QaseemA, UsmanN, JayarajJS, JanapalaRN, KashifT. Cancer of unknown primary: a review on clinical guidelines in the development and targeted management of patients with the unknown primary site. Cureus. 2019;11(9):e5552. Published 2019 Sep 2. doi:10.7759/cureus.555231695975
   PubMed Web of Science ®Google Scholar
• AngK, HarrisJ, WheelerR, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35. doi:10.1056/NEJMoa091221720530316
   PubMed Web of Science ®Google Scholar
• LigeyA, GentilJ, CréhangeG, et al. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiother Oncol. 2009;93(3):483–487. PMID: 19892420. doi:10.1016/j.radonc.2009.08.02719892420
   PubMed Web of Science ®Google Scholar
• JensenDH, HedbackN, SpechtL, et al. Human papillomavirus in head and neck squamous cell carcinoma of unknown primary is a common event and a strong predictor of survival. PLoS One. 2014;9(11):e110456. doi:10.1371/journal.pone.011045625369118
   PubMed Web of Science ®Google Scholar
• ZhuL, WangN. 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a diagnostic tool in patients with cervical nodal metastases of unknown primary site: a meta-analysis. Surg Oncol. 2013;22:190–194. doi:10.1016/j.suronc.2013.06.00223849685
   PubMed Web of Science ®Google Scholar
• MollerAK, LoftA, BerthelsenAK, et al. A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site. Oncologist. 2012;17:1146–1154. doi:10.1634/theoncologist.2011-044922711751
   PubMed Web of Science ®Google Scholar
• MaghamiE, IsmailaN, AlvarezA, et al. Diagnosis and management of squamous cell carcinoma of unknown primary in the head and neck: ASCO guideline. J Clin Oncol. 2020;22:2570–2596. doi:10.1200/JCO.20.00275
   Web of Science ®Google Scholar
• BinderC, MatthesKL, KorolD, RohrmannS, MochH. Cancer of unknown primary-epidemiological trends and relevance of comprehensive genomic profiling. Cancer Med. 2018;7(9):4814–4824. PMID: 30019510; PMCID: PMC6144156. doi:10.1002/cam4.168930019510
   PubMed Web of Science ®Google Scholar
• Al KadahB, PapaspyrouG, LinxweilerM, et al. Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients. Eur Arch Otorhinolaryngol. 2017;274(6):2. doi:10.1007/s00405-017-4525-8
   Web of Science ®Google Scholar
• HainsworthJD, SpigelDR, ThompsonDS, et al. Paclitaxel/carboplatin plus bevacizumab/erlotinib in the first-line treatment of patients with carcinoma of unknown primary site. Oncologist. 2009;14(12):1189–1197. doi:10.1634/theoncologist.2009-011219965914
   PubMed Web of Science ®Google Scholar
• KrämerA, HübnerG, SchneeweissA, FolprechtG, NebenK. Carcinoma of unknown primary - an orphan disease?Breast Care. 2008;3(3):164–170. doi:10.1159/00013600120824034
   PubMed Web of Science ®Google Scholar
• GrauC, JohansenLV, JakobsenJ, GeertsenP, AndersenE, JensenBB. Cervical lymph node metastases from unknown primary tumours: results from a national survey by the Danish society for head and neck oncology. Radiother Oncol. 2000;55:121–129. doi:10.1016/S0167-8140(00)00172-910799723
   PubMed Web of Science ®Google Scholar